AQUINOX PHARMACEUTICALS INC's ticker is AQXP and the CUSIP is 03842B101. A total of 41 filers reported holding AQUINOX PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $10,525,000 | +186.4% | 747,500 | +139.2% | 1.12% | +67.1% |
| Q4 2017 | $3,675,000 | -17.1% | 312,500 | 0.0% | 0.67% | -33.4% |
| Q3 2017 | $4,434,000 | -40.0% | 312,500 | -40.5% | 1.01% | -42.6% |
| Q2 2017 | $7,387,000 | -49.6% | 525,000 | -40.2% | 1.76% | -45.1% |
| Q1 2017 | $14,650,000 | +1.1% | 877,753 | 0.0% | 3.20% | -42.9% |
| Q4 2016 | $14,492,000 | +23.6% | 877,753 | 0.0% | 5.61% | +6.7% |
| Q3 2016 | $11,727,000 | +101.8% | 877,753 | 0.0% | 5.26% | +2.0% |
| Q2 2016 | $5,811,000 | -19.7% | 877,753 | +7.0% | 5.15% | -27.2% |
| Q1 2016 | $7,233,000 | -28.4% | 820,015 | +1.3% | 7.08% | -18.8% |
| Q4 2015 | $10,101,000 | – | 809,415 | – | 8.72% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 1,396,071 | $19,643,000 | 2.25% |
| Boxer Capital, LLC | 525,000 | $7,387,000 | 1.76% |
| Baker Brothers Advisors | 10,934,154 | $153,844,000 | 1.34% |
| EMORY UNIVERSITY | 105,815 | $1,489,000 | 1.32% |
| Ghost Tree Capital, LLC | 300,000 | $4,221,000 | 0.88% |
| UNIVERSITY OF NOTRE DAME DU LAC | 171,217 | $2,409,000 | 0.71% |
| NEXTHERA CAPITAL LP | 90,700 | $1,276,000 | 0.56% |
| Eventide Asset Management | 175,000 | $2,462,000 | 0.15% |
| SPHERA FUNDS MANAGEMENT LTD. | 62,085 | $874,000 | 0.15% |
| ASCEND CAPITAL, LLC | 214,328 | $3,017,000 | 0.14% |